Artivion Inc (AORT): Congress and insider trades
Who in Congress and inside the company traded AORT, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Artivion Inc (AORT) is a listed stock on NYSE.
- 3 members of Congress filed 7 buys and 1 sell of AORT, the latest published 2026-09-11 (11 September 2026).
- Insiders filed 0 open market buys worth $0 and 6 sells worth $3.5M, the latest filed 2026-09-11 (11 September 2026).
- Across 3 scored buys, Congress averaged +10.0% against the S&P 500 (SPY) over the 90 days after disclosure, with 67% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in AORT
as of 2026-09-11| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 11 Sep 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 21 | n/a |
| 7 Sep 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 50 | n/a |
| 19 Nov 2023 | Tina Smith (D-MN) | buy | 50K–100K | 10 | +22.8% |
| 19 Nov 2023 | Tina Smith (D-MN) | buy | 50K–100K | 4 | +22.8% |
| 24 Aug 2023 | Josh Gottheimer (D-NJ) | buy | 1K–15K | 38 | -4.3% |
| 12 Jul 2023 | Josh Gottheimer (D-NJ) | sell | 1K–15K | 28 | n/a |
| 17 Oct 2022 | Tina Smith (D-MN) | buy | 50K–100K | 24 | +11.5% |
| 6 Nov 2020 | Josh Gottheimer (D-NJ) | buy | 1K–15K | 20 | n/a |
Nothing matches that search.
Insider trades in AORT
as of 2026-09-11| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 11 Sep 2026 | GREEN ANDREW M | sell | 11,480 | $24.97 | $287K | n/a |
| 4 Sep 2026 | GREEN ANDREW M | sell | 1,493 | $26.02 | $38.8K | n/a |
| 4 Sep 2026 | GREEN ANDREW M | sell | 6,510 | $27.27 | $177K | n/a |
| 20 Aug 2026 | Mackin James P | sell | 70,000 | $28.95 | $2.0M | n/a |
| 12 Aug 2026 | Holloway Jean F | sell | 977 | $28.49 | $27.8K | n/a |
| 15 Jun 2026 | GREEN ANDREW M | sell | 44,001 | $20.70 | $911K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought AORT?
7 Congress buys by 3 members and 0 insider buys are on file. The tables on this page list every one.
Did buying AORT after a disclosure beat the market?
Across 3 scored buys, Congress averaged +10.0% against the S&P 500 (SPY) over the 90 days after disclosure, with 67% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.